Pharmacology of a mimetic of glutathione disulfide, NOV-002

Biomedicine and Pharmacotherapy

Volumn 63, Issue 2, 2009, Pages 75-78

  Townsend, Danyelle M ^a   Tew, Kenneth D ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Glutathione; Redox; S Glutathionylation; Thiols

Indexed keywords

BIOLOGICAL MARKER; CARBOPLATIN; CELL SURFACE PROTEIN; CISPLATIN; ETOPOSIDE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; NOV 002; PACLITAXEL; PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN DISULFIDE ISOMERASE; THIOL; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ARTICLE; BONE MARROW; CANCER THERAPY; CHEMICAL REACTION; CLINICAL TRIAL; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNOREGULATION; KARNOFSKY PERFORMANCE STATUS; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN S GLUTATHIONYLATION; SURVIVAL RATE; TUMOR REGRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; CLINICAL TRIALS AS TOPIC; DRUG COMBINATIONS; GLUTATHIONE DISULFIDE; HUMANS; LUNG NEOPLASMS; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE;

EID: 58949103855     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.08.019     Document Type: Article

References (28)

1. Pazoles C.J., and Gernstein H. NOV-002, a chemoprotectant/immunomodulator, added to first line carboplatin/paclitaxel in advanced non-small cell lung cancer (NSCLC): a randomized phase 1/2, open label, controlled study (2006), American Society of Oncology [abstract # 17021]
2. Tew K.D., Bomber A.M., and Hoffman S.J. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res 48 (1988) 3622-3625
3. Bailey H.H., Ripple G., Tutsch K.D., Arzoomanian R.Z., Alberti D., Feierabend C., et al. Phase I study of continuous-infusion l-S, R-buthionine sulfoximine with intravenous melphalan. J Natl Cancer Inst 89 (1997) 1789-1796
4. O'Dwyer P.J., LaCreta F., Nash S., Tinsley P.W., Schilder R., Clapper M.L., et al. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res 51 (1991) 6059-6065
5. Ruscoe J.E., Rosario L.A., Wang T., Gate L., Arifoglu P., Wolf C.R., et al. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 298 (2001) 339-345
6. Gate L., Majumdar R.S., Lunk A., and Tew K.D. Increased myeloproliferation in glutathione S-transferase pi-deficient mice is associated with a deregulation of JNK and Janus kinase/STAT pathways. J Biol Chem 279 (2004) 8608-8616
7. Adler V., Yin Z., Fuchs S.Y., Benezra M., Rosario L., Tew K.D., et al. Regulation of JNK signaling by GSTp. Embo J 18 (1999) 1321-1334
8. Wang T., Arifoglu P., Ronai Z., and Tew K.D. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 276 (2001) 20999-21003
9. Peterson J.D., Herzenberg L.A., Vasquez K., and Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci U S A 95 (1998) 3071-3076
10. Herzenberg L.A., De Rosa S.C., Dubs J.G., Roederer M., Anderson M.T., Ela S.W., et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci U S A 94 (1997) 1967-1972
11. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 263 (1988) 17205-17208
12. Wang J., Boja E.S., Tan W., Tekle E., Fales H.M., English S., et al. Reversible glutathionylation regulates actin polymerization in A431 cells. J Biol Chem 276 (2001) 47763-47766
13. Townsend D.M. S-glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 7 (2007) 313-324
14. Townsend D.M., He L., Hutchens S., Garrett T.E., Pazoles C.J., and Tew K.D. NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance. Cancer Res 68 (2008) 2870-2877
15. Brennan J.P., Miller J.I., Fuller W., Wait R., Begum S., Dunn M.J., et al. The utility of N,N-biotinyl glutathione disulfide in the study of protein S-glutathiolation. Mol Cell Proteomics 5 (2006) 215-225
16. Pompella A., Corti A., Paolicchi A., Giommarelli C., and Zunino F. Gamma-glutamyltransferase, redox regulation and cancer drug resistance. Curr Opin Pharmacol 7 (2007) 360-366
17. Sekhar K.R., Spitz D.R., Harris S., Nguyen T.T., Meredith M.J., Holt J.T., et al. Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of gamma-glutamylcysteine synthetase. Free Radic Biol Med 32 (2002) 650-662
18. 2 production and S-thiolation. Free Radic Biol Med 27 (1999) 623-635
19. Jordan P.A., and Gibbins J.M. Extracellular disulfide exchange and the regulation of cellular function. Antioxid Redox Signal 8 (2006) 312-324
20. Matthias L.J., and Hogg P.J. Redox control on the cell surface: implications for HIV-1 entry. Antioxid Redox Signal 5 (2003) 133-138
21. Lahav J., Wijnen E.M., Hess O., Hamaia S.W., Griffiths D., Makris M., et al. Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1. Blood 102 (2003) 2085-2092
22. Goplen D., Wang J., Enger P.O., Tysnes B.B., Terzis A.J., Laerum O.D., et al. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res 66 (2006) 9895-9902
23. Smith J., Ladi E., Mayer-Proschel M., and Noble M. Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci U S A 97 (2000) 10032-10037
24. Noble M., Mayer-Proschel M., and Proschel C. Redox regulation of precursor cell function: insights and paradoxes. Antioxid Redox Signal 7 (2005) 1456-1467
25. O'Shea J.J., Gadina M., and Schreiber R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 Suppl (2002) S121-S131
26. Tew K.D. Redox in redux: emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochem Pharmacol 73 (2007) 1257-1269
27. Filomeni G., Aquilano K., Civitareale P., Rotilio G., and Ciriolo M.R. Activation of c-Jun-N-terminal kinase is required for apoptosis triggered by glutathione disulfide in neuroblastoma cells. Free Radic Biol Med 39 (2005) 345-354
28. Filomeni G., Rotilio G., and Ciriolo M.R. Glutathione disulfide induces apoptosis in U937 cells by a redox-mediated p38 MAP kinase pathway. Faseb J 17 (2003) 64-66